Reading this on a mobile device? Try our optimized mobile version here:

June 11, 2012
Sign upForwardArchiveAdvertise
News for diabetes health professionals

  Diabetes in Focus 
  • More U.S. children develop diabetes, study finds
    The number of U.S. children with type 1 and type 2 diabetes grew 23% and 21%, respectively, between 2001 and 2009, according to a study presented at the ADA 72nd Scientific Sessions. More children with type 2 diabetes had protein in their urine than those with type 1 diabetes, indicating that they could be at higher risk of kidney damage, researchers noted. Yahoo!/HealthDay News (6/12) LinkedInFacebookTwitterEmail this Story
  • Many patients fail to meet type 1 diabetes targets
    A study presented at the ADA 72nd Scientific Sessions showed many adult patients with type 1 diabetes are overweight or obese with elevated blood glucose levels. Researchers also found that blacks were more likely than whites to have higher mean A1C levels. Lower glucose rates in both adult and young patients were linked to more frequent self-monitoring of blood glucose, reduced insulin resistance and more use of newer technologies, according to the study, which was based on data from the T1D Exchange Clinic Registry. HealthDay News (6/9) LinkedInFacebookTwitterEmail this Story
  • Mildly obese diabetes patients benefit from gastric bypass
    Almost 90% of type 2 diabetes patients with a BMI between 30 and 35 kg/m2 who underwent gastric bypass surgery had a remission of their disease and attained significant improvements in blood glucose levels and decreased use of oral anti-diabetes drugs, a study published in Diabetes Care and presented at the ADA 72nd Scientific Sessions revealed. Researchers also noted a lower risk of coronary heart disease and stroke in many of the gastric bypass patients. MedPage Today (free registration) (6/10) LinkedInFacebookTwitterEmail this Story
  • Lantus outshines Januvia in curbing blood glucose levels
    Type 2 diabetes patients who took Sanofi's Lantus insulin attained greater reductions in blood glucose levels compared with those who took Merck & Co.'s Januvia, researchers reported at the ADA 72nd Scientific Sessions. However, higher rates of hypoglycemic episodes and weight gain were seen in patients who took Lantus than those who had Januvia. The Wall Street Journal (6/9) LinkedInFacebookTwitterEmail this Story
Support DiabetesPro SmartBrief
DiabetesPro SmartBrief is the daily e-news resource for 29,000 influential leaders in diabetes care. E-mail Aaron Kern for more information on advertising.

  Nutrition & Wellness 
  • Unhealthy foods are more appealing to sleep-deprived people
    A study presented at the Associated Professional Sleep Societies meeting found that seeing junk food stimulates the reward centers of the brain in sleep-deprived people, but not in people who were well rested. "The results suggest that, under restricted sleep, individuals will find unhealthy foods highly salient and rewarding, which may lead to greater consumption of those foods," said lead researcher Marie-Pierre St-Onge. United Press International (6/10) LinkedInFacebookTwitterEmail this Story
  Practice Update 
  • Report: U.S. hospitals work toward equal health care
    Data from an American Hospital Association report showed 80% of U.S. hospitals translated health documents into languages most used by patients using standard methods, while 62% used interviews or surveys to collect data on patient satisfaction for serving diverse populations. The Health Research & Educational Trust report also found that 54% of hospitals have implemented initiatives to improve health care quality in diverse groups. (6/7) LinkedInFacebookTwitterEmail this Story
  Trends & Technology 
  • Survey: Consumers want calorie counts on convenience foods
    More than three-quarters of U.S. consumers want to see calorie counts on hot dogs, sandwiches and other ready-to-eat foods they buy at convenience stores and supermarkets, according to a new survey. "Menu labeling at chain restaurants will be enormously helpful. But it doesn't make sense to create loopholes for certain companies, when that's not what Congress intended and it's not what people want," said Margo G. Wootan, director of nutrition policy at the Center for Science in the Public Interest. Consumer blog (6/6), United Press International (6/4) LinkedInFacebookTwitterEmail this Story
  ADA Scientific Sessions Preview 
  • ADA task force is developing disaster response systems
    The ADA has developed a task force to make disaster response recommendations and create best practices for first responders in the wake of lessons learned during Hurricane Katrina and the storm's aftermath. The ADA also has a new strategic plan to promote new research priorities and new transformational approaches to treatment, as well as a new series of grants that encourage more risk-taking in research. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Award winner discusses genetics research
    Research into the relationship between genetics and type 2 diabetes is the subject of this year's ADA Outstanding Scientific Achievement Award winner Dr. David Altshuler's presentation. Altshuler has gained recognition for his work to use the Human Genome Project, population genetics and other research to examine the inherited basis of type 2 diabetes, cholesterol levels and myocardial infarctions. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Lecturer objects to "epidemic" to describe global diabetes situation
    The use of the word "epidemic" to describe the global situation with diabetes is a misnomer, according to this year's Kelly West Award lecturer, Knut Borch-Johnsen of the Institute for Public Health at South Denmark University. He says that while the number of people with diabetes has been increasing, mortality is decreasing and the incidence of diabetes has remained flat or declined, showing the success of diabetes treatment. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Research shows effects of carb intake on atherogenic dyslipidemia
    A moderate reduction in carbohydrate intake can have similar benefits in overweight and obese people as losing 15 to 20 pounds in terms of atherogenic dyslipidemia risks, data indicate. Researchers also have found that low-fat, high-carbohydrate diets increase risks in healthy individuals with an atherogenic dyslipidemia phenotype. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Technology should advance, not replace, clinical care
    Online and telephone-based treatment for diabetes self-management should be complementary to, not a replacement for, personal clinical care, said Lawrence Fisher, Behavioral Medicine and Psychology Interest Group Award Lecture presenter. Web-based technology can aid treatment but does not take into account the beliefs, challenges and drivers behind an individual's behavior changes, Fisher said. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • ORIGIN trial results to be presented in symposium today
    The design, conduct and results from the six-year ORIGIN trial will be the focus of a symposium today seeking to clarify the effects of insulin therapy. The study was designed to track the impact of insulin therapy on cardiovascular events compared to standard treatments and to determine if omega-3 fatty acids can be used to reduce cardiovascular mortality in a dysglycemic population. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Session looks at 90 years of insulin therapy progress
    The development of insulin therapy over the last 90 years was part of a discussion Sunday on new findings in research on the use of basal insulins, bolus insulins and insulin co-formations. Presenters discussed new research into rapid-acting insulin analogs and inhaled insulin. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Research seeks to clarify link between insulin glargine and cancer
    The session "Cancer Link with Insulin -- Data from the U.S. and Northern Europe" today will look at results from comprehensive studies designed to assess whether insulin glargine causes cancer. The studies to be presented "have looked at the question of insulin and cancer more robustly than has ever been done previously," Dr. John B. Buse said. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  Conference Information 
  • Meeting updates and highlights
    The 72nd Scientific Sessions website will include a page listing program updates and changes as they happen. The page will also include daily meeting highlights and events. Learn more. LinkedInFacebookTwitterEmail this Story
  • Get the 72nd Scientific Sessions App!
    Planning your time at the Scientific Sessions is only a click away with the on-the-go Scientific Sessions App! This application gives direct and instant access to meeting information from your smartphone, tablet or other handheld device. Features include interactive program and course schedules, customizable calendar and itinerary builder, exhibitor listing with interactive booth map, social media interaction and special meeting alerts. Learn more. LinkedInFacebookTwitterEmail this Story
  • Diabetes Dispatch Newspaper
    Read the full newspaper of the 72nd Scientific Sessions to learn about what's happening at the meeting this year. Read it now. LinkedInFacebookTwitterEmail this Story
Most people never run far enough on their first wind to find out they've got a second."
--William James,
American psychologist and philosopher

LinkedInFacebookTwitterEmail this Story


Product announcements appearing in SmartBrief are paid advertisements and do not reflect actual American Diabetes Association endorsements. The news reported in SmartBrief does not necessarily reflect the official position of American Diabetes Association.
Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Aaron Kern (202) 407-7866
A powerful website for SmartBrief readers including:
 Recent DiabetesPro SmartBrief Issues:   Lead Editor:  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information